Omega Healthcare (DE:WX4)
FRANKFURT:WX4
Holding DE:WX4?
Track your performance easily

Omega Healthcare (WX4) Stock Forecast & Price Target

1 Followers
See the Price Targets and Ratings of:

WX4 Analyst Ratings

Moderate Buy
10Ratings
3 Buy
7 Hold
0 Sell
Based on 10 analysts giving stock ratings to
Omega
Healthcare
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

WX4 Stock 12 Month Forecast

Average Price Target

€30.82
▼(-2.76% Downside)
Based on 10 Wall Street analysts offering 12 month price targets for Omega Healthcare in the last 3 months. The average price target is €30.82 with a high forecast of €34.89 and a low forecast of €25.71. The average price target represents a -2.76% change from the last price of €31.69.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"24":"€24","35":"€35","26.75":"€26.8","29.5":"€29.5","32.25":"€32.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":34.8935,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€34.89</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":30.81647,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€30.82</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":25.711,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€25.71</span>\n  </div></div>","useHTML":true}}],"tickPositions":[24,26.75,29.5,32.25,35],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Oct<br/>2023","6":"Jan<br/>2024","9":"Apr<br/>2024","12":"Jul<br/>2024","25":"Jul<br/>2025"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,31.14,31.42873076923077,31.71746153846154,32.00619230769231,32.29492307692308,32.58365384615385,32.87238461538462,33.161115384615385,33.44984615384615,33.73857692307693,34.027307692307694,34.31603846153846,34.604769230769236,{"y":34.8935,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,31.14,31.115113076923077,31.090226153846153,31.06533923076923,31.04045230769231,31.015565384615385,30.99067846153846,30.965791538461538,30.940904615384614,30.91601769230769,30.89113076923077,30.866243846153846,30.841356923076923,{"y":30.81647,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,31.14,30.722384615384616,30.30476923076923,29.887153846153847,29.469538461538463,29.051923076923078,28.634307692307694,28.216692307692306,27.79907692307692,27.381461538461537,26.963846153846152,26.546230769230768,26.128615384615383,{"y":25.711,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":26.235,"date":1689292800000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":26.786,"date":1691107200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":28.284,"date":1693526400000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":29.361,"date":1696550400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":27.77,"date":1698969600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":28.057,"date":1701388800000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":26.48,"date":1704412800000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":25.537,"date":1706832000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":27.69,"date":1709251200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":27.836,"date":1712275200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":28.98,"date":1714694400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":29.51,"date":1717718400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":31.14,"date":1720137600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target€34.89Average Price Target€30.82Lowest Price Target€25.71
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Citi
€29.38€32.14
Buy
1.42%
Upside
Upgraded
03/21/24
Omega Healthcare upgraded to Buy from Neutral at CitiOmega Healthcare upgraded to Buy from Neutral at Citi
Exane BNP Paribas
€27.55
Hold
-13.07%
Downside
Upgraded
02/08/24
Omega Healthcare upgraded to Neutral from Underperform at Exane BNP ParibasOmega Healthcare upgraded to Neutral from Underperform at Exane BNP Paribas
Bank of America Securities
€30.3€28.47
Hold
-10.17%
Downside
Downgraded
01/16/24
Omega Healthcare downgraded to Neutral from Buy at BofAOmega Healthcare downgraded to Neutral from Buy at BofA
Wedbush
€29.38€30.3
Hold
-4.38%
Downside
Reiterated
01/02/24
Omega Healthcare Investors (OHI) PT Raised to $33 at WedbushWedbush analyst Richard Anderson raised the price target on Omega Healthcare Investors (NYSE: OHI) to $33.00 (from $32.00) while maintaining a Neutral rating.
Raymond James
€30.3€33.06
Buy
4.31%
Upside
Reiterated
09/20/23
Omega Healthcare price target raised to $36 from $33 at Raymond JamesOmega Healthcare price target raised to $36 from $33 at Raymond James

Best Analysts Covering Omega Healthcare

Which Analyst Should I Follow If I Want to Buy DE:WX4 and Sell After:
1 Month
xxx
Success Rate
14/19 ratings generated profit
74%
Average Return
+3.25%
reiterated a xxx
rating a year ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 73.68% of your transactions generating a profit, with an average return of +3.25% per trade.
3 Months
xxx
Success Rate
8/10 ratings generated profit
80%
Average Return
+7.61%
reiterated a xxx
rating a year ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 80.00% of your transactions generating a profit, with an average return of +7.61% per trade.
1 Year
Jonathan HughesRaymond James
Success Rate
16/19 ratings generated profit
84%
Average Return
+13.72%
reiterated a buy rating a year ago
Copying Jonathan Hughes's trades and holding each position for 1 Year would result in 84.21% of your transactions generating a profit, with an average return of +13.72% per trade.
2 Years
xxx
Success Rate
9/10 ratings generated profit
90%
Average Return
+22.44%
reiterated a xxx
rating a year ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 90.00% of your transactions generating a profit, with an average return of +22.44% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

WX4 Analyst Recommendation Trends

Rating
Mar 24
Apr 24
May 24
Jun 24
Jul 24
Strong Buy
0
0
0
0
0
Buy
6
4
2
5
5
Hold
13
9
10
9
9
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
19
13
12
14
14
In the current month, WX4 has received 5 Buy Ratings, 9 Hold Ratings, and 0 Sell Ratings. WX4 average Analyst price target in the past 3 months is €30.82.
Each month's total comprises the sum of three months' worth of ratings.
Stocks with the Highest Top Analyst Consensus in the Real Estate Sector
Find stocks in the Real Estate sector that are highly recommended by Top Performing Analysts.

WX4 Financial Forecast

WX4 Earnings Forecast

Next quarter’s earnings estimate for WX4 is €0.33 with a range of €0.30 to €0.35. The previous quarter’s EPS was €0.25. WX4 beat its EPS estimate 25.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 17.65% of the time in the same period. In the last calendar year WX4 has Outperformed its overall industry.
Next quarter’s earnings estimate for WX4 is €0.33 with a range of €0.30 to €0.35. The previous quarter’s EPS was €0.25. WX4 beat its EPS estimate 25.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 17.65% of the time in the same period. In the last calendar year WX4 has Outperformed its overall industry.

WX4 Sales Forecast

Next quarter’s sales forecast for WX4 is €189.09M with a range of €178.80M to €197.24M. The previous quarter’s sales results were €225.80M. WX4 beat its sales estimates 100.00% of the time in past 12 months, while its overall industry beat sales estimates 91.43% of the time in the same period. In the last calendar year WX4 has Outperformed its overall industry.
Next quarter’s sales forecast for WX4 is €189.09M with a range of €178.80M to €197.24M. The previous quarter’s sales results were €225.80M. WX4 beat its sales estimates 100.00% of the time in past 12 months, while its overall industry beat sales estimates 91.43% of the time in the same period. In the last calendar year WX4 has Outperformed its overall industry.

WX4 Stock Forecast FAQ

What is DE:WX4’s average 12-month price target, according to analysts?
Based on analyst ratings, Omega Healthcare’s 12-month average price target is €30.82.
    What is DE:WX4’s upside potential, based on the analysts’ average price target?
    Currently there's no upside potential for DE:WX4, based on the analysts’ average price target.
    Can I see which stocks the top-ranking analysts are rating?
    Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
      How can I follow the stock ratings of top Wall Street analysts?
      Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
        Is Omega Healthcare a Buy, Sell or Hold?
        Omega Healthcare has a consensus rating of Moderate Buy, which is based on 3 buy ratings, 7 hold ratings and 0 sell ratings.
          What is Omega Healthcare’s share price target?
          The average share price target for Omega Healthcare is €30.82. This is based on 10 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
          The highest analyst share price target is €34.89 ,and the lowest forecast is €25.71. The average share price target represents -2.76% Decrease from the current price of €31.69.
            What do analysts say about Omega Healthcare?
            Omega Healthcare’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 10 Wall Streets Analysts.
              How can I buy shares of Omega Healthcare?
              To buy shares of DE:WX4, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis